VAERS reports by lot

GSK Varicella/Shingles lot 5G7A7: VAERS reports

31 VAERS reports list lot 5G7A7 as a GSK Varicella/Shingles vaccine, received between 2019-01-11 and 2020-03-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
31
Reports
6%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3930%
Injection-site / Local reaction2116%
Neurological1713%
Dermatological (non-injection-site)1713%
Musculoskeletal119%
Cardiac / Cardiovascular86%
Gastrointestinal75%
Respiratory32%
Allergic / Anaphylactic22%
Psychiatric / Neuropsychiatric22%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Washington5
Missouri4
Michigan3
Oregon3
Nevada2
Colorado1
Illinois1
Georgia1
Texas1
Kentucky1
Tennessee1
Iowa1

Reports by month received

2019-019
2019-026
2019-035
2019-041
2019-057
2019-072
2020-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.